Evidence map›Paper›PMID 32983975›Full record

ArticleFrontiers in oncology2020

A Case-Control Study of

Xu Chao, Yong Jia, Xuesong Feng, Guoquan Wang, Xiaoping Wang, Hailong Shi, Fei Zhao, Chao Jiang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xu ChaoThe College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China.
Yong JiaThe Affiliated Hospital, Shaanxi University of Chinese Medicine, Xianyang, China.
Xuesong FengThe College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China.
Guoquan WangThe College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.
Xiaoping WangThe College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China.
Hailong ShiThe College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China.
Fei ZhaoThe College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China.
Chao JiangDepartment of Neurology, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Shaanxi University of Chinese Medicine · CNAffiliated Hospital of Shaanxi University of Chinese Medicine · CNXi'an Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADCY9case–control studyhepatocellular carcinoma riskpolymorphismsstratification analysis

Identifiers

PMID32983975
PMCPMC7477943
OpenAlexW3080812357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.